Opaleye Management
Opaleye Management reported 58 stocks worth $888M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are ETON (14.2%), IRON (8.1%) and HROW (7.3%). Compared with Q2 2026, the fund opened new positions in SMMT, HRMY and GRCE, added to IRON, SLGL and MGTX, trimmed ETON, HROW and LQDA and sold out of NTLA, PHAT and COAG.
Latest filing: what Opaleye Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() ETON Eton Pharmaceuticals Inc | $126M | 14.2% | 2.4M | −420K (−15%) | 8 of 8 | |
| 2 | ![]() IRON Disc Medicine Inc | $71.7M | 8.1% | 1.1M | +240K (+28%) | 7 of 8 | |
| 3 | ![]() HROW Harrow Inc | $64.8M | 7.3% | 2.1M | −295K (−12%) | 8 of 8 | |
| 4 | ![]() LQDA Liquidia Corporation | $63.8M | 7.2% | 2.1M | −338K (−14%) | 8 of 8 | |
| 5 | ![]() URGN Urogen Pharma Ltd | $58.5M | 6.6% | 1.4M | No change | 5 of 8 | |
| 6 | ![]() SLGL Sol Gel Technologies | $41.2M | 4.6% | 555K | +55K (+11%) | 5 of 8 | |
| 7 | ![]() MGTX Meiragtx Hldgs PLC | $39.6M | 4.5% | 3.6M | +50K (+1%) | 4 of 8 | |
| 8 | ![]() TGTX TG Therapeutics Inc | $31.1M | 3.5% | 557K | +22K (+4%) | 8 of 8 | |
| 9 | ![]() ACOG Alpha Cognition Inc | $29.7M | 3.4% | 3.3M | +408K (+14%) | 5 of 8 | |
| 10 | ![]() IMMX Immix Biopharma Inc | $29.4M | 3.3% | 2.8M | +480K (+20%) | 2 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
APOGEE THERAPEUTICS INC | $51.8M | 390K |
XOMA ROYALTY CORPORATION | $14.4M | 338K |
![]() NTLA Intellia Therapeutics Inc | $4.2M | 250K |
![]() PHAT Phathom Pharmaceuticals Inc | $2M | 186K |
![]() COAG Hemab Therapeutics Hldgs Inc | $1.8M | 48K |
🔒 Free account: see all 10.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Opaleye Management 13F FAQ
What does Opaleye Management own?
Opaleye Management reported 58 stocks worth $888M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are ETON (14.2%), IRON (8.1%) and HROW (7.3%). The table above lists every position in the filing (the top 10 without an account).
What did Opaleye Management buy and sell in Q3 2026?
Compared with Q2 2026: 10 new positions, 17 added to, 19 trimmed and 10 sold out. New positions include SMMT, HRMY and GRCE. It sold all of NTLA, PHAT and COAG.
When will Opaleye Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Opaleye Management's portfolio worth?
The Q3 2026 filing reports $888M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.























